Testosterone and Growth Hormone for Bone Loss in Men
Will Testosterone and Growth Hormone Improve Bone Structure?
Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Listed as NCT00080483, this PHASE2 trial focuses on Growth Hormone Deficiency and Hypogonadism and remains completed. Sponsored by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), it has been updated 6 times since 2004, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE2
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE2
-
Feb 2017 — Jun 2018 [monthly]
Completed PHASE2
▶ Show 1 earlier version
-
Jan 2017 — Feb 2017 [monthly]
Completed PHASE2
First recorded
Mar 2004
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
- University of Pennsylvania
For direct contact, visit the study record on ClinicalTrials.gov .